Recent Quotes
My Watchlist
Indicators
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ProKidney Corp. - Class A Ordinary Shares (NQ:PROK)

2.800 +0.100 (+3.70%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ProKidney Corp. - Class A Ordinary Shares

< Previous 1 2 3 4 5 6 Next >
ProKidney Corp (NASDAQ:PROK) Reports Q3 2025 Earnings and Clinical Progress
ProKidney (PROK) reports Q3 2025 results, beating EPS estimates. Key updates include strong Phase 3 trial enrollment and a confirmed FDA accelerated approval pathway for its kidney disease therapy. 
Via Chartmill
Eledon Pharmaceuticals (ELDN) Plummets Nearly 50% Amidst Mixed Phase 2 Trial Results, Sparking Investor Concern
San Diego, CA – November 10, 2025 – Eledon Pharmaceuticals (NASDAQ: ELDN) witnessed a dramatic collapse in its stock price, shedding nearly 50% of its value following the announcement of mixed results... 
Via MarketMinute
ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates
From ProKidney
Via GlobeNewswire
ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025
From ProKidney
Via GlobeNewswire
ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference
From ProKidney
Via GlobeNewswire
ProKidney Announces Two Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2025
From ProKidney
Via GlobeNewswire
SPAC King Chamath Palihapitiya Tells Retail Investors To Stay Away From His New SPAC
Chamath Palihapitiya is back with another SPAC. This time he's telling retail investors to stay away. Here's why. 
Via Benzinga
Which stocks are experiencing notable movement on Friday?
Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
What's going on in today's session
Curious to know what's happening on the US markets one hour before the close of the markets on Thursday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
ProKidney to Participate in Two Upcoming Conferences: the Citi Biopharma Back to School Conference and the Morgan Stanley Global Healthcare Conference
From ProKidney
Via GlobeNewswire
Prediction: Chamath Palihapitiya's $250 Million SPAC Could Create the Next Palantir for America's Energy Grid
Chamath Palihapitiya is launching a $250 million SPAC, called American Exceptionalism Acquisition Corp. 
Via The Motley Fool
Topics Artificial Intelligence Economy
Chamath Palihapitiya Returns To SPACs: Past 18 Deals, Investments Average Loss Of 14%
Chamath Palihapitiya is back with a new SPAC. Many investors will remember past SPACs the investor was involved with and the poor performance track record. 
Via Benzinga
ProKidney Reports 78 Percent Gain in Q2
Via The Motley Fool
Topics Intellectual Property
ProKidney Corp (NASDAQ:PROK) Reports Mixed Q2 2025 Results with Regulatory Progress and Narrower Loss
ProKidney Corp. (PROK) reports Q2 2025 results with unexpected revenue and a narrower loss than expected. FDA progress on rilparencel and Phase 3 trial updates highlight key milestones. Cash runway... 
Via Chartmill
ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates
From ProKidney
Via GlobeNewswire
Meet the Biotech Stock That Rocketed 775% Higher
Via The Motley Fool
This Biotech Stock Jumped Over 600% in Just Days After Releasing Promising Clinical Trial Data. And Its Market Cap Is Still Only $2 Billion. But Is It a Buy?
Via The Motley Fool
Unusual volume stocks are being observed in Tuesday's session.
The trading volume of these stocks is deviating from the norm in today's session. 
Via Chartmill
Simulations Plus, FB Financial And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
 
Via Benzinga
ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel
From ProKidney
Via GlobeNewswire
These stocks are moving in today's session
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
In today's session, these stocks are experiencing unusual volume.
Let's have a look at what is happening on the US markets on Thursday. Below you can find the stocks with an unusual volume in today's session. 
Via Chartmill
AZZ Posts Better-Than-Expected Earnings, Joins MP Materials, WK Kellogg And Other Big Stocks Moving Higher On Thursday
 
Via Benzinga
Get insights into the top gainers and losers of Thursday's pre-market session.
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Why WK Kellogg Shares Are Trading Higher By Over 50%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Which stocks are most active on Wednesday?
Get a pulse on the US markets on Wednesday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity. 
Via Chartmill
Which stocks have an unusual volume on Wednesday?
Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume. 
Via Chartmill
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.